Infinium Pharmachem Limited has announced the allotment of 7.2 lakh equity shares to renowned investor Ashish Kacholia as part of a preferential issue. The shares, with a face value of ₹10 each, are being issued at a price of ₹246.57 per share, which includes a premium of ₹236.57 per share. This transaction amounts to approximately ₹17.75 crores.
The overall preferential issue comprises 16.67 lakh equity shares, aggregating a total value of ₹41.10 crores. Other key allottees include Everest Finance & Investment Company (represented by Ashish Agarwal), Rahul Batra, and various public investors, with Everest Finance also receiving 7.2 lakh shares.
The issuance is in line with SEBI regulations and the Companies Act, 2013. The approval was made during the company’s board meeting held on October 1, 2024. The shares are set to be issued in cash, and the allotment is subject to approval from the members of the company and other regulatory authorities.
The company has also appointed M/s. RTBR & Associates as the scrutinizer for the e-voting process in preparation for its upcoming Extraordinary General Meeting (EGM) scheduled for October 23, 2024.
Ahmedabad Plane Crash